Deutsche Bank Ag\ Kala Pharmaceuticals, Inc. Transaction History

Deutsche Bank Ag\

$218 Billion
Q2 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$0.3 - $1.31 $8,448 - $36,890	-28,161 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$0.61 - $1.84 $1,904 - $5,744	-3,122 Reduced 9.98%	28,161 $39,000
Q4 2021 Feb 11, 2022	BUY	$1.16 - $2.74 $1,804 - $4,263	1,556 Added 5.23%	31,283 $38,000
Q3 2021 Nov 04, 2021	SELL	$2.62 - $5.43 $788,331 - $1.63 Million	-300,890 Reduced 91.01%	29,727 $78,000
Q2 2021 Aug 11, 2021	BUY	$5.06 - $8.15 $15,245 - $24,555	3,013 Added 0.92%	330,617 $1.75 Million
Q1 2021 May 13, 2021	BUY	$6.24 - $9.58 $1.86 Million - $2.85 Million	297,594 Added 991.65%	327,604 $2.21 Million
Q4 2020 Feb 16, 2021	BUY	$6.28 - $8.79 $47,125 - $65,960	7,504 Added 33.34%	30,010 $204,000
Q3 2020 Nov 12, 2020	SELL	$7.5 - $11.11 $156,045 - $231,154	-20,806 Reduced 48.04%	22,506 $168,000
Q2 2020 Aug 13, 2020	BUY	$8.33 - $13.79 $295,673 - $489,476	35,495 Added 454.07%	43,312 $454,000
Q1 2020 May 14, 2020	BUY	$3.83 - $8.79 $214 - $492	56 Added 0.72%	7,817 $69,000
Q4 2019 Feb 14, 2020	BUY	$3.36 - $4.81 $6,602 - $9,451	1,965 Added 33.9%	7,761 $28,000
Q3 2019 Nov 14, 2019	SELL	$3.57 - $6.58 $34,607 - $63,786	-9,694 Reduced 62.58%	5,796 $21,000
Q2 2019 Aug 14, 2019	SELL	$4.93 - $8.8 $12,339 - $22,026	-2,503 Reduced 13.91%	15,490 $97,000
Q1 2019 May 15, 2019	SELL	$5.19 - $8.97 $1.3 Million - $2.24 Million	-250,061 Reduced 93.29%	17,993 $147,000
Q4 2018 Feb 14, 2019	BUY	$4.29 - $9.94 $865,863 - $2.01 Million	201,833 Added 304.79%	268,054 $1.31 Million
Q3 2018 Dec 21, 2021	BUY	$9.54 - $13.87 $62,992 - $91,583	6,603 Added 11.08%	66,221 $654,000
Q3 2018 Nov 14, 2018	BUY	$9.54 - $13.87 $283,290 - $411,869	29,695 Added 99.24%	59,618 $588,000
Q2 2018 Apr 21, 2020	BUY	$13.3 - $17.49 $92,421 - $121,538	6,949 Added 30.25%	29,923 $411,000
Q2 2018 Aug 14, 2018	BUY	$13.3 - $17.49 $10,759 - $14,149	809 Added 3.65%	22,974 $315,000
Q1 2018 Oct 18, 2019	BUY	$12.26 - $18.98 $76,465 - $118,378	6,237 Added 39.16%	22,165 $350,000
Q1 2018 May 15, 2018	SELL	$12.26 - $18.98 $38,839 - $60,128	-3,168 Reduced 16.59%	15,928 $251,000
Q4 2017 Feb 14, 2018	BUY	$13.68 - $23.17 $145,705 - $246,783	10,651 Added 126.12%	19,096 $352,000
Q3 2017 Nov 14, 2017	BUY	$19.86 - $26.53 $167,717 - $224,045	8,445	8,445 $191,000

Others Institutions Holding KALA

# of Institutions

Shares Held

Call Options Held

Put Options Held

Parallel Advisors, LLC

1
Shares

$5
0.0% of portfolio

View Full List

About Kala Pharmaceuticals, Inc.

Ticker KALA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,464,160
Market Cap $7.83M
Description
Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...

More about KALA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account